Clinical and genetic characteristics of children with acute lymphoblastic leukemia and Li–Fraumeni syndrome
Open Access
- 12 February 2021
- journal article
- letter
- Published by Springer Science and Business Media LLC in Leukemia
- Vol. 35 (5), 1475-1479
- https://doi.org/10.1038/s41375-021-01163-y
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- CAR T-cell therapy for a relapsed/refractory acute B-cell lymphoblastic lymphoma patient in the context of Li-Fraumeni syndromeJournal for ImmunoTherapy of Cancer, 2019
- The landscape of genomic alterations across childhood cancersNature, 2018
- TP53Variations in Human Cancers: New Lessons from the IARC TP53 Database and Genomics DataHuman Mutation, 2016
- Consensus definitions of 14 severe acute toxic effects for childhood lymphoblastic leukaemia treatment: a Delphi consensusThe Lancet Oncology, 2016
- Germline Mutations in Predisposition Genes in Pediatric CancerThe New England Journal of Medicine, 2015
- Mutations and Deletions of the TP53 Gene Predict Nonresponse to Treatment and Poor Outcome in First Relapse of Childhood Acute Lymphoblastic LeukemiaJournal of Clinical Oncology, 2011
- Hypercalcemia in Acute Lymphoblastic LeukemiaJournal of Pediatric Hematology/Oncology, 2009
- Hypercalcemia Associated with CancerThe New England Journal of Medicine, 2005
- Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li–Fraumeni syndromeNature, 1990
- Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other NeoplasmsScience, 1990